Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

New atomic sensor technology enhances MRI quality control by tracking hyperpolarized molecules in real-time, with potential ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

A clinical trial sponsored by the National Institutes of Health (NIH) has launched to examine the safety and acceptability of ...

Here is how Biogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Product- Multiple Sclerosis (MS)- Fumarate- ...

Iron tablets come in various formulations like ferrous sulfate, ferrous fumarate, ferrous gluconate, ferrous ascorbate, and ...

New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the phase III clinical ...

The atomic sensors' unprecedented resolution and real-time tracking allowed them to witness how the polarization in a metabolite compound ([1-13 C]-fumarate) evolved under the presence of a ...

The notice of claim contends Gilead developed two drugs, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide fumarate (TAF). TDF is “effective in managing HIV/AIDS but can damage patients’ ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.